Ora Israel
Department of Nuclear Medicine
Rambam Health Care Campus
Haifa
Israel
Name/email consistency: high
- Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care. Israel, O., Kuten, A. J. Nucl. Med. (2007)
- PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. Israel, O., Weiler-Sagie, M., Rispler, S., Bar-Shalom, R., Frenkel, A., Keidar, Z., Bar-Shalev, A., Strauss, H.W. J. Nucl. Med. (2007)
- FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. Israel, O., Goldberg, A., Nachtigal, A., Militianu, D., Bar-Shalom, R., Keidar, Z., Fogelman, I. Eur. J. Nucl. Med. Mol. Imaging (2006)
- PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. Israel, O., Yefremov, N., Bar-Shalom, R., Kagana, O., Frenkel, A., Keidar, Z., Fischer, D. J. Nucl. Med. (2005)
- Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?. Israel, O., Mor, M., Guralnik, L., Hermoni, N., Gaitini, D., Bar-Shalom, R., Keidar, Z., Epelbaum, R. J. Nucl. Med. (2004)
- Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma. Israel, O., Mor, M., Epelbaum, R., Frenkel, A., Haim, N., Dann, E.J., Gaitini, D., Bar-Shalom, R., Kolodny, G.M., Front, D. Cancer (2002)
- Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG. Israel, O., Mor, M., Gaitini, D., Keidar, Z., Guralnik, L., Engel, A., Frenkel, A., Bar-Shalom, R., Kuten, A. J. Nucl. Med. (2002)
- Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment. Israel, O., Mekel, M., Bar-Shalom, R., Epelbaum, R., Hermony, N., Haim, N., Dann, E.J., Frenkel, A., Ben-Arush, M., Gaitini, D. J. Nucl. Med. (2002)
